ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Glomerular Diseases: 2024 Update

Course Description

Glomerular medicine is exploding with exciting new understanding of disease pathogenesis, which has led to developments in novel genetic and serological diagnostic tools, clinical trials, and potential treatments. This program explores novel changes in IgAN/Henoch-Schonlein purpura, lupus nephritis, podocytopathies (FSGS/minimal change disease), membranous GN, atypical hemolytic uremic syndrome/C3 glomerulopathy, diabetic kidney disease, glomerular disease as "CKD," and monoclonal gammopathy of renal significance. Hot topics are reviewed, including how and when to use genetics in the diagnosis and treatment of glomerular diseases, chimeric antigen receptor T cell therapy, balancing cost and efficacy of new medications for glomerular diseases, and precision medicine and clinical trials. Experts present cutting-edge clinical applications in treatment, pathology, and genetics that continue to change the diagnostic and therapeutic landscape in glomerular diseases.

ASN designates this live course for a maximum of 8.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Objective(s)

Upon completion of this program, the participant will be able to: 1) describe the pathophysiology, pathology, diagnostics, and therapeutic options for glomerular diseases; 2) summarize information from current basic and clinical research studies and apply to the diagnosis and management of glomerular diseases; 3) analyze nuances in the treatment of patients with difficult-to-manage glomerular diseases; and 4) discuss when to use novel medications and/or to enroll patients in clinical trials as medical therapy options.

Course Chair(s)

Session(s)

  • Glomerular Diseases: 2024 Update
    October 23, 2024 | 07:00 AM - 06:00 PM
    Location: Ballroom 20D, Convention Center |
  • Glomerular Diseases: 2024 Update

    October 23, 2024 | 07:00 AM - 06:00 PM

    Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

Register for this Early Program

Early Programs have limited capacity and fill up fast. Click the button below to register online.

Register Online